Agf Investments LLC Ultragenyx Pharmaceutical Inc. Transaction History

Agf Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$106.9 - $167.73 $19,242 - $30,191	-180 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$84.4 - $177.39 $15,192 - $31,930	180 New	180 $25,000
Q4 2018 Feb 08, 2019	SELL	$38.89 - $77.3 $4,122 - $8,193	-106 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$71.81 - $90.15 $9,335 - $11,719	-130 Reduced 55.08%	106 $8,000
Q2 2018 Aug 13, 2018	BUY	$48.54 - $85.31 $11,455 - $20,133	236 New	236 $18,000

329

85.9M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.18B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Agf Investments LLC with notifications on news.